Introduction
The centipede is a kind of arthropod that belongs to the class Chilopoda, subphylum Myriapoda. There are ~7,000 species of centipedes in the world, and over 3,000 species have been described [1] . Among these centipedes, Scolopendra subspinipes mutilans (a relatively large centipede) has been used in oriental medicine for the treatment of various diseases [14] . Nevertheless, the pharmacological basis of the activity of this large centipede has yet to be understood thoroughly, and little is known about the antimicrobial peptides (AMPs) of the centipede. Only a few AMPs (i.e., scolopendrin I and scolopin 1 and -2) from the venom of the centipede S. subspinipes mutilans have been reported [15, 20] . Both scolopin-1 and -2 demonstrated strong antimicrobial activities against gram-positive/negative bacteria and fungi [15] . In arthropods, it has been documented that evolutionarily conserved AMPs play a major role in mediating resistance to microbial infections [2] .
AMPs are ubiquitous in nature, having been identified and isolated from various sources within living organisms [6, 16] . Over the past two decades, numerous antibiotic peptides have been studied from a wide variety of insects [4] , amphibians [5] , and mammals, including humans [13] . AMPs are composed of a small number of amino acid residues (below 10 kDa), and their secondary structure consists of an α-helical and/or β-sheet [10] . They show amphipathic characteristics and a positive net charge, with broad-spectrum activity against a diverse array of microbes, such as bacteria, fungi, and viruses [8] . There is an urgent need to develop alternative antimicrobial agents; recently, AMPs have been studied as candidate sources for novel antibiotics [11] .
AMPs can be exploited using DAMPD [17] (formerly ANTIMIC [3] ), which has recently been updated. Using the Web server, a variety of AMP families can be predicted en masse and subsequently classified. In this study, we characterized a new antimicrobial peptide, scolopendrasin II, from the centipede S. subpinipes mutilans and confirmed its antimicrobial activity.
Materials and Methods

Peptide Synthesis
The synthetic peptide, named scolopendrasin II, was synthesized using solid-phase peptide synthesis methods by Anygen Co., Ltd. (Gwangju, Korea). The peptide was dissolved in acidified distilled water (0.01% acetic acid) and stored at -20 o C until use.
Antimicrobial Assays
The antimicrobial activity of each peptide was tested by radial diffusion assay, colony count assay, and the specific binding of scolopendrasin II to the cell-wall components. For the colony count assay, scolopendrasin II was mixed with mid-logarithmic phase Staphylococcus epidermidis, Propionibacterium acnes, or multidrug-resistant Pseudomonas aeruginosa (MDRPA) in a sterile 10 mM sodium phosphate buffer (pH 7.4) according to the predetermined concentrations (Fig. 2) . Mixtures were incubated for 1 h at 37 o C in a shaking incubator. After incubation, 10 µl aliquots were directly, or after 10 times dilution with the buffer, removed and plated on tryptic soy bacto-agar (1.5% in TSB). The resulting colonies were counted after an overnight incubation. The tested microorganisms were Candida albicans (KCTC7121), Escherichia coli (KACC13821), Propionibacterium acnes (KCTC3314), Streptococcus pyogenes (KACC11956), Staphylococcus epidermidis (KACC13234), and MDRPA (CCARM2002). All microorganisms were purchased from the Culture Collection of Antibiotic-Resistant Microbes (CCARM) at Seoul Women's University, the Korean Agricultural Culture Collection (KACC), and the Korean Collection for Type Cultures (KCTC).
Hemolytic Activity
For the hemolytic assay, 20 µl of the peptide sample at a predetermined concentration was added to 180 µl of a 2.5% (v/v) suspension of rat erythrocytes in phosphate-buffered saline (PBS). Melittin (Sigma, USA), a hemolytic and α-helical peptide isolated from bee venom, was used as the positive control. The mixture was incubated for 30 min at 37 o C, and 600 µl of PBS was added to each tube. After 3 min of centrifugation at 10,000 ×g, the supernatant was removed, and the absorbance was measured at 540 nm.
Assay for Binding of Scolopendrasin II to the Components of the Bacterial Cell Wall
The binding of scolopendrasin II to the surface of bacteria was examined by assessing the effect of the cell-wall components on the anti-MDRPA activity of scolopendrasin II, using a radial diffusion assay [19] . One microgram of scolopendrasin II was incubated with varying concentrations of laminarin, mannan, lipopolysaccharide (LPS), or lipoteichoic acid (LTA) for 10 min at 37 o C in 10 mM sodium phosphate buffer (pH 7.4). Then, 5 µl samples of each mixture was loaded into wells (3 mm diameter) that had been punched into the underlying agar containing washed mid-logarithmic MDRPA (4 × 10 6 colony-forming units).
The underlay agar consisted of 9 mM sodium phosphate, 1 mM sodium citrate buffer, 1% (w/v) agarose (A6013, Sigma), and 0.3 mg of tryptic soy broth (TSB; Difco). After incubation at 37 o C for 3 h, a 10 ml overlay agar containing 1% agarose and 6% TSB was poured onto the underlay agar.
Results and Discussion
Peptide
In order to discover a novel antimicrobial peptide, we used a support vector machine (SVM) algorithm operating on a database of 1,232 experimentally validated AMPs. The "AMP predictor" tool was optimized to predict AMPs in various organisms, including mammals, amphibians, and insects (http://apps.sanbi.ac.za/dampd/). In the present study, we sought to identify novel AMPs using an "AMP predictor" with a default threshold value using insecta taxonomy after searching for homologs of several kinds of AMPs in the UniProtKB. The tool was based on SVM, which can very faithfully classify a peptide into 1 out of 27 possible AMP families. Among 242 Unigenes, with no matches in the UniProtKB, a new AMP was identified as MCD mastoparan (Unigene70841) ( Antimicrobial activity was predicted by models built through SVM using the "AMP Prediction" tool of DAMPD (http://apps.sanbi.ac.za/dampd/).
b p-value < 0.05.
